6-{4-[ω-(1-Imidazolyl)-alkyl]-phenyl}-3-oxo-2,3,4,5-tetrahydro-pyridazines and acid addition salts thereof, and a process for the treatment of inflammatory, arteriosclerosic and thromboembolic illnesses in humans
The complete official wording is available by downloading the pdf-file above right.